GGrantIndex
Sort

78,016 grants matching breast cancer

KanSurvive: Testing a model for improving cancer survivorship care in rural practice

$452,796
Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2021 · CA

QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS

$452,790
Joseph A O'Sullivan · Washington University · R01 · FY2020 · CA

Virtual Breast Project: Improving Noninvasive Characterization of Tumors

$452,780
Jingfeng Jiang · Michigan Technological University · R15 · FY2014 · CA

ANTIPROLIFERATIVE AND ANTI-INFLAMMATORY ER AGENTS FOR TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER

$452,774
University Of Illinois · · FY2013 · Department of Defense

High-Resolution Whole-Breast MRI at 3.0T

$452,773
Brian Andrew Hargreaves · Stanford University · R01 · FY2009 · EB

Role of Apobecs in Retroviral Immunity

$452,755
Jaquelin Page Dudley · University Of Texas At Austin · R01 · FY2021 · AI

Role of Apobecs in Retroviral Immunity

$452,755
Jaquelin Page Dudley · University Of Texas At Austin · R01 · FY2019 · AI

Role of Apobecs in Retroviral Immunity

$452,755
Jaquelin Page Dudley · University Of Texas At Austin · R01 · FY2020 · AI

Role of Apobecs in Retroviral Immunity

$452,755
Jaquelin Page Dudley · University Of Texas At Austin · R01 · FY2018 · AI

Mapping & quantifying lymphatic drainage of the arm's alternate pathway

$452,750
Dhruv Singhal · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL

TSPO Ligands for Cancer Imaging

$452,739
Henry Charles Manning · Vanderbilt University · R01 · FY2012 · CA

TSPO Ligands for Cancer Imaging

$452,739
Henry Charles Manning · Vanderbilt University Medical Center · R01 · FY2016 · CA

Cohort Study of Genetic Susceptibility to Breast Cancer

$452,731
Brigham And Women'S Hospital · R01 · FY2002 · CA

Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer

$452,729
Sarah H. Elsea · Baylor College Of Medicine · R01 · FY2021 · CA

A New Generation Clinical Decision Support System

$452,719
Xia Jiang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · LM

Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival

$452,706
David Spiegel · Stanford University · R01 · FY2008 · CA

Role of Gi/o-GPCR signaling in breast cancer progression

$452,692
Songhai Chen · University Of Iowa · R01 · FY2019 · CA

WOMEN VETERANS AND BREAST CANCER SCREENING

$452,667
University Of Texas Hlth Sci Ctr Houston · R01 · FY2003 · CA

III: Small: Topology-based approaches to integrated analysis of transcriptomic, protein interactomic and phenotypic data

$452,657
Jianhua Ruan · University Of Texas At San Antonio · · FY2012 · CSE

A kinase-independent role for EGFR in p38MAPK suppression and S-phase progression in head and neck cancer

$452,656
Alan C Rapraeger · University Of Wisconsin-Madison · R01 · FY2021 · DE

Molecular Approaches to Understanding Global Regulation in Paclitaxel Accumulatio

$452,630
Susan Celia Roberts · University Of Massachusetts Amherst · R01 · FY2009 · GM

Machine learning methods for interpreting spatial multi-omics data

$452,625
Elham Azizi · Columbia Univ New York Morningside · R01 · FY2023 · HG

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy

$452,540
Richard T Lee · Beckman Research Institute/City Of Hope · R21 · FY2022 · CA

Targeting CD5 on Tumor-associated T and B cells to improve PD-1 blockade in Breast Cancer

$452,540
Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2020 · CA

VEGFs in tumor lymphatic metastasis

$452,526
Harold Fisher Dvorak · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA